Therefore, the addition of IL-6 blockers, as well as of a PD-L1 inhibitor could be useful in cancer treatment whenever previous testing for PD-L1 expression on the resident cells of a tumor has been demonstrated, so that the inhibitor will truly have an effect [24]. The gene discussed is CD274; the disease is neoplasm.